An End to Grant Writing Nightmares?

Federal grant proposal writing may be an art, but for many busy researchers it can quickly turn to a grind: Compiling biographical sketches, doing the project write-up. Figuring the budget. Refiguring the budget. Calculating that budget yet again. Before the application ends up in the National Institutes of Health mailroom, it can undergo more incarnations than psychic Edgar Cayce. Cayuse Inc., a small company based in Portland, Ore., (www.cayuse.com), created a software program called GrantSl

Written byPaula Park
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Cayuse Inc., a small company based in Portland, Ore., (www.cayuse.com), created a software program called GrantSlam in the mid-1990s to reduce the grant writer's workload. The company recently updated the program by transferring it from a Form Flow (produced by Jetform) to a FileMaker database platform and adding other innovations. The newest version, 4.1, released this spring with 4.0 bugs repaired, includes graphical icons and colorful boxes. It copies and calculates data across sections and self-saves the proposal for use with future drafts.

According to one user, without using a program like GrantSlam, it's easy to make mistakes on the application, and once that happens, related pages have to be readjusted. The GrantSlam program automatically adjusts the related entries. The table of contents--a particularly trying because it is completed last--is generated automatically as the writer fills out other forms, says Brian Davis, associate professor of anatomy and neural biology at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies